search
Back to results

The Time-Restricted Intake of Meals Study (TRIM)

Primary Purpose

PreDiabetes, Obesity

Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Time-restricted feeding
Usual feeding pattern
Sponsored by
Johns Hopkins University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for PreDiabetes

Eligibility Criteria

21 Years - 69 Years (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • Prediabetes defined by HbA1c 5.7-6.4%, or type 2 diabetes with HbA1c 6.5-6.9%
  • Class I-III obesity (BMI 30-50 kg/m2)
  • If on medications for hypertension, stable regimen for at least past 6 months
  • Willingness to adjust timing of feeding
  • Willingness and ability to eat study diet and nothing else during run-in and intervention
  • Willingness to complete measurement procedures

Exclusion Criteria:

  • Moderate to severe obstructive sleep apnea
  • Shift work;
  • Other sleep/circadian disorders: e.g., circadian phase delay or phase advance; restless legs syndrome, insomnia, narcolepsy, habitual sleep <6 hours/night
  • Routinely ate within compressed time window in the past year (e.g., routinely eats all food within an 10-hour or narrower window, follows an intermittent fasting protocol)
  • Renal dysfunction (estimated Glomerular Filtration Rate (GFR) <30 using the simplified Chronic Kidney Disease (CKD) Epidemiology Collaboration (EPI) equation 34)
  • Use of glucose-lowering medications, weight loss medications, medications for sleep disorders (sedative/hypnotic drugs, stimulants), lithium, systemic corticosteroids, diuretics, blood thinners requiring regular monitoring (e.g. warfarin), anti-psychotic drugs and antiretroviral therapy
  • Body weight >400 pounds (limitation of facility scales)
  • >1 drink per day of alcohol
  • Active substance use disorder or significant psychiatric/psychologic disorder that would interfere with participation
  • Significant food allergies, preferences, intolerances, or dietary supplements that would interfere with diet adherence
  • Weight loss or gain of ≥5% during past 6 months
  • Pregnant, planning to become pregnant, or breastfeeding
  • Planning to start a weight loss program
  • Planning to leave the area prior to end of study
  • Current participation in another clinical trial
  • Cancer diagnosis requiring active treatment in past two years or planned treatment (with exception of localized non-melanoma skin cancer)
  • Active inflammatory bowel disease, malabsorption, or history of major gastrointestinal surgery involving bowel resection
  • Myocardial infarction or stroke in past 6 months
  • Prior bariatric surgery
  • Any serious illness that would interfere with participation
  • Other conditions or situations at the discretion of the PI

Sites / Locations

  • Johns Hopkins ProHealth

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Other

Arm Label

Time-restricted feeding

Usual feeding pattern

Arm Description

Comparison

Outcomes

Primary Outcome Measures

Weight Change
Weight change will be measured in kg

Secondary Outcome Measures

Fasting glucose
Change in fasting glucose
HOMA-IR
Change in HOMA-IR
AUC glucose
Area-under-the-curve for glucose on OGTT
Glycated albumin
Glycated albumin

Full Information

First Posted
May 4, 2018
Last Updated
May 13, 2021
Sponsor
Johns Hopkins University
Collaborators
American Heart Association
search

1. Study Identification

Unique Protocol Identification Number
NCT03527368
Brief Title
The Time-Restricted Intake of Meals Study
Acronym
TRIM
Official Title
The Time-Restricted Intake of Meals Study: A Randomized, Controlled Feeding Study
Study Type
Interventional

2. Study Status

Record Verification Date
May 2021
Overall Recruitment Status
Completed
Study Start Date
September 24, 2018 (Actual)
Primary Completion Date
December 23, 2019 (Actual)
Study Completion Date
December 31, 2019 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Johns Hopkins University
Collaborators
American Heart Association

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
TRIM is a randomized, controlled feeding study to evaluate if eating earlier in the day vs. later in the day impacts weight and glucose homeostasis.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
PreDiabetes, Obesity

7. Study Design

Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
41 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Time-restricted feeding
Arm Type
Experimental
Arm Title
Usual feeding pattern
Arm Type
Other
Arm Description
Comparison
Intervention Type
Behavioral
Intervention Name(s)
Time-restricted feeding
Intervention Description
Participants consume food earlier in the day
Intervention Type
Behavioral
Intervention Name(s)
Usual feeding pattern
Intervention Description
Participants consume food later in the day
Primary Outcome Measure Information:
Title
Weight Change
Description
Weight change will be measured in kg
Time Frame
12 weeks
Secondary Outcome Measure Information:
Title
Fasting glucose
Description
Change in fasting glucose
Time Frame
12 weeks
Title
HOMA-IR
Description
Change in HOMA-IR
Time Frame
12 weeks
Title
AUC glucose
Description
Area-under-the-curve for glucose on OGTT
Time Frame
12 weeks
Title
Glycated albumin
Description
Glycated albumin
Time Frame
12 weeks

10. Eligibility

Sex
All
Minimum Age & Unit of Time
21 Years
Maximum Age & Unit of Time
69 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Prediabetes defined by HbA1c 5.7-6.4%, or type 2 diabetes with HbA1c 6.5-6.9% Class I-III obesity (BMI 30-50 kg/m2) If on medications for hypertension, stable regimen for at least past 6 months Willingness to adjust timing of feeding Willingness and ability to eat study diet and nothing else during run-in and intervention Willingness to complete measurement procedures Exclusion Criteria: Moderate to severe obstructive sleep apnea Shift work; Other sleep/circadian disorders: e.g., circadian phase delay or phase advance; restless legs syndrome, insomnia, narcolepsy, habitual sleep <6 hours/night Routinely ate within compressed time window in the past year (e.g., routinely eats all food within an 10-hour or narrower window, follows an intermittent fasting protocol) Renal dysfunction (estimated Glomerular Filtration Rate (GFR) <30 using the simplified Chronic Kidney Disease (CKD) Epidemiology Collaboration (EPI) equation 34) Use of glucose-lowering medications, weight loss medications, medications for sleep disorders (sedative/hypnotic drugs, stimulants), lithium, systemic corticosteroids, diuretics, blood thinners requiring regular monitoring (e.g. warfarin), anti-psychotic drugs and antiretroviral therapy Body weight >400 pounds (limitation of facility scales) >1 drink per day of alcohol Active substance use disorder or significant psychiatric/psychologic disorder that would interfere with participation Significant food allergies, preferences, intolerances, or dietary supplements that would interfere with diet adherence Weight loss or gain of ≥5% during past 6 months Pregnant, planning to become pregnant, or breastfeeding Planning to start a weight loss program Planning to leave the area prior to end of study Current participation in another clinical trial Cancer diagnosis requiring active treatment in past two years or planned treatment (with exception of localized non-melanoma skin cancer) Active inflammatory bowel disease, malabsorption, or history of major gastrointestinal surgery involving bowel resection Myocardial infarction or stroke in past 6 months Prior bariatric surgery Any serious illness that would interfere with participation Other conditions or situations at the discretion of the PI
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Nisa Maruthur, MD
Organizational Affiliation
Johns Hopkins University
Official's Role
Principal Investigator
Facility Information:
Facility Name
Johns Hopkins ProHealth
City
Baltimore
State/Province
Maryland
ZIP/Postal Code
21207
Country
United States

12. IPD Sharing Statement

Learn more about this trial

The Time-Restricted Intake of Meals Study

We'll reach out to this number within 24 hrs